About
BRC Therapeutics develops prescription medicines based on cannabinoids to treat pain and neurological and inflammatory conditions, currently conducting clinical trials for Complex Regional Pain Syndrome and Aromatase Inhibitor-Induced Arthralgia.
Explore BRC Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.